- Presentations
- 4
- Markets
- 1
Invokamet XR is a brand of Canagliflozin and Metformin marketed by Janssen Pharmaceuticals, with 4 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Canagliflozin and Metformin
- Brand owner
- Janssen Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 150 mg/1000 mg extended-release tablet, 150 mg/500 mg extended-release tablet, 50 mg/1000 mg extended-release tablet, 50 mg/500 mg extended-release tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Invokamet XR 150 mg/1000 mg extended-release tabletOral | Janssen Pharmaceuticals | US FDA | Available on request |
| Invokamet XR 150 mg/500 mg extended-release tabletOral | Janssen Pharmaceuticals | US FDA | Available on request |
| Invokamet XR 50 mg/1000 mg extended-release tabletOral | Janssen Pharmaceuticals | US FDA | Available on request |
| Invokamet XR 50 mg/500 mg extended-release tabletOral | Janssen Pharmaceuticals | US FDA | Available on request |
Equivalent brands
Other brands of Canagliflozin and Metformin.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Invokamet XR
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.